Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Gyre Therapeutics Inc (GYRE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Gyre Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
15.4100 -0.4300    -2.71%
- Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 38,002
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 15.1150 - 15.9450
Gyre Therapeutics 15.4100 -0.4300 -2.71%

GYRE Recent Sentiments

 
This page contains information on users’ sentiments for the Gyre Therapeutics Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Apr 03, 2024 Aderson Isaac   15.8000 Apr 08, 2024 @ 16.8500 +6.65%
Feb 23, 2024 浩二 竹本   17.4638 Mar 08, 2024 @ 19.5200 +11.77%
Jan 24, 2024 Suharjono SUHARJONO   13.8875 Feb 16, 2024 @ 15.3800 +10.75%
Jan 24, 2024 浩二 竹本   15.1090 Feb 16, 2024 @ 15.3800 +1.79%
Dec 26, 2023 Geraldo de Souza   27.9600 Jan 01, 2024 @ 25.6900 +8.12%
Dec 18, 2023 博之 遠藤   23.3100 Dec 18, 2023 @ 23.3100 0.00%
Dec 18, 2023 Yasin Evkaya   23.8400 Dec 25, 2023 @ 29.6800 +24.50%
Dec 11, 2023 焱 殷   20.7650 Jan 05, 2024 @ 23.6900 +14.09%
Dec 11, 2023 直樹 井上   20.7650 Jan 05, 2024 @ 23.6900 -14.09%
Dec 06, 2023 浩二 竹本   19.0000 Dec 29, 2023 @ 25.6900 +35.21%
Dec 04, 2023 תמר כהן   19.5600 Dec 29, 2023 @ 25.6900 +31.34%
Dec 04, 2023 Yasin Evkaya   21.6000 Dec 11, 2023 @ 22.1054 +2.34%
Nov 30, 2023 直樹 井上   21.6500 Nov 30, 2023 @ 21.6500 0.00%
Nov 30, 2023 Yasin Evkaya   23.1187 Dec 04, 2023 @ 21.7550 -5.90%
Nov 30, 2023 Marion Cobretti   23.1400 Dec 22, 2023 @ 29.6800 +28.26%
Nov 28, 2023 Tuulberg Index   20.9300 Dec 04, 2023 @ 21.7550 +3.94%
Nov 24, 2023 Yasin Evkaya   19.0775 Nov 30, 2023 @ 26.3000 +37.86%
Nov 21, 2023 kermit dekikker   12.3309 Dec 15, 2023 @ 24.5200 -98.85%
Oct 30, 2023 josef haddad   8.1200 Nov 30, 2023 @ 26.3000 +223.89%
Oct 26, 2023 Josef Haddad   8.2500 Nov 30, 2023 @ 26.3000 +218.79%
Oct 23, 2023 一真 大軒   7.1200 Nov 30, 2023 @ 26.3000 -269.38%
Oct 16, 2023 Franz Welti   5.9600 Nov 30, 2023 @ 26.3000 -341.28%
Oct 04, 2023 Diego Lissignoli   6.7900 Nov 30, 2023 @ 26.3000 +287.33%
Sep 27, 2023 Majed Alomari   7.5000 Nov 30, 2023 @ 26.3000 +250.67%
Aug 24, 2023 Marion Cobretti   8.1000 Nov 30, 2023 @ 26.3000 +224.69%
Aug 18, 2023 Ashok Patel   7.9500 Nov 30, 2023 @ 26.3000 +230.82%
Aug 18, 2023 Robbert Kuipers   8.1000 Nov 30, 2023 @ 26.3000 +224.69%
Aug 18, 2023 Robbert Kuipers   0.5300 Aug 18, 2023 @ 0.5300 0.00%
Aug 17, 2023 Robbert Kuipers   7.6500 Nov 30, 2023 @ 26.3000 +243.79%
Aug 17, 2023 Robbert Kuipers   0.5100 Aug 17, 2023 @ 0.5100 0.00%
Jul 18, 2023 Peter Meško   6.6000 Nov 30, 2023 @ 26.3000 +298.48%
Jun 23, 2023 Narciso Junior   0.3070 Jul 14, 2023 @ 0.3501 +14.04%
Jun 21, 2023 Harikumar Unnikrishna   0.3730 Jun 21, 2023 @ 0.3330 -10.72%
Mar 27, 2023 juan luis Rodriguez...   0.1950 Apr 21, 2023 @ 0.2400 +23.08%
Mar 20, 2023 Caramel Net   0.1910 Apr 14, 2023 @ 0.2100 +9.95%
Mar 07, 2023 Stoop Ljhbb   0.2350 Mar 31, 2023 @ 0.2070 -11.91%
Mar 02, 2023 Glenn Hargis   0.2420 Mar 24, 2023 @ 0.2080 +14.05%
Feb 28, 2023 Frédéric TAILLEZ   0.3110 Mar 24, 2023 @ 0.2080 -33.12%
Feb 28, 2023 Mikael griego   0.2940 Mar 06, 2023 @ 0.2400 +18.37%
Feb 28, 2023 Alfredo Silva   0.3080 Mar 24, 2023 @ 0.2080 -32.47%
Feb 28, 2023 Marion Cobretti   0.3310 Mar 24, 2023 @ 0.2080 -37.16%
Feb 24, 2023 Rotari Tatiana   0.2430 Feb 27, 2023 @ 0.2480 +2.06%
Feb 02, 2023 mgogel   0.3050 Feb 24, 2023 @ 0.2400 -21.21%
Jan 17, 2023 جوال جو   0.2650 Jan 23, 2023 @ 0.2800 +5.66%
Jan 13, 2023 roberto ponzo   0.2800 Feb 03, 2023 @ 0.2910 +4.11%
Jan 13, 2023 جوال جو   0.2550 Jan 16, 2023 @ 0.2620 +2.94%
Jan 13, 2023 Loris Scomazzon   0.2500 Feb 03, 2023 @ 0.2910 +16.60%
Jan 13, 2023 Marion Cobretti   0.2390 Feb 03, 2023 @ 0.2910 +21.97%
Jan 13, 2023 נתן שאקו natan shako   0.2320 Feb 03, 2023 @ 0.2910 +25.65%
Jan 13, 2023 UP oUP   0.2750 Feb 03, 2023 @ 0.2910 -6.00%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GYRE Comments

Write your thoughts about Gyre Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Nov 15, 2021 8:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
needs better leadership
Duane Goodson
Duane Goodson Jan 04, 2021 11:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
RDGL 0.125 By 1/16/2021 FDA will provide a final decision to grant or deny their request for breakthrough designation.
Alex Levin
Alex Levin Nov 20, 2020 1:24PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hope that in long term it will rise
Episcopolian OptionTrader
Episcopolian1 Sep 15, 2017 11:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Phase 1/2 completion of dosing announced June 14, 2017 with data due by the end of September.. Data will be excellent! The stock will rock once again!
Al Trader
Al Trader Sep 14, 2017 5:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
To holders of CBIO: Patience will pay off. Between now and December we should have a major event that would restore the fair price to this stock.
Episcopolian OptionTrader
Episcopolian1 Sep 13, 2017 10:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Catalyst Biosciences Announces Issuance of Asia Patents Covering Factor IX Hemophilia Program. . 8:01 am ET September 11, 2017 (Globe Newswire) Print
Al Trader
Al Trader Sep 13, 2017 9:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
CBIO is warming up to something. Maybe good news is in the way. I feel something good is coming
Al Trader
Al Trader Sep 11, 2017 1:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why are you selling your shares cheep. Some one is accumulating for the big day.
Episcopolian OptionTrader
Episcopolian1 Jul 05, 2017 3:59PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Watch out for $CBIO as secondary offering lock-up expires tomorrow 7/6/17
Episcopolian OptionTrader
Episcopolian1 Mar 28, 2017 12:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Something I read from an analyst opinion column today about this . . This is a great news for $CBIO for being able to partner with "ISU Abxis"ISU Abxis is the beggest Biotech ion Korea with annual revenue of $30B.. Furthermore, they are doing some fantastic blood cancer work. If they agreed to $CBIO data, that means something....
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email